Know Cancer

or
forgot password

Phase II Multicenter Clinical Trial on Surgery for Patients With Resectable Hepatic Metastasis From Gastrointestinal Stromal Tumors (GISTs)


Phase 2
20 Years
N/A
Open (Enrolling)
Both
Gastrointestinal Stromal Tumor, Metastatic Cancer

Thank you

Trial Information

Phase II Multicenter Clinical Trial on Surgery for Patients With Resectable Hepatic Metastasis From Gastrointestinal Stromal Tumors (GISTs)


OBJECTIVES:

- To evaluate the safety and efficacy of surgery in patients with resectable hepatic
metastasis secondary to gastrointestinal stromal tumor.

OUTLINE: This is a multicenter study.

Patients undergo surgical resection of hepatic metastasis.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of gastrointestinal stromal tumor (GIST)

- Hepatic metastasis meeting the following criteria:

- Clinically diagnosed as surgically resectable with no macroscopic residual tumor

- No more than 3 hepatic metastases

- Synchronous hepatic metastasis allowed provided primary tumor is also resectable

- Does not require radiofrequency ablation and/or microwave coagulation therapy to
control the disease

- No extrahepatic metastasis

- No history of GIST recurrence

PATIENT CHARACTERISTICS:

- ECOG performance status 0-1

- Leukocyte count ≥ 3,000/μL

- Neutrophil count ≥ 1,500/μL

- Hemoglobin ≥ 8.0 g/dL

- Platelet count ≥ 75,000/μL

- Total bilirubin ≤ 2.0 mg/dL

- ALT and AST < 120 IU/L

- GTP < 210 IU/L

- Not pregnant

- No poorly controlled diabetes mellitus

- No NYHA class III-IV cardiac function

- No hepatitis B or hepatitis B carriers

- No other malignancy requiring treatment

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- No prior interventional radiology for metastatic disease

- No prior or concurrent imatinib mesylate

- No other concurrent treatment

Type of Study:

Interventional

Study Design:

Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Recurrence-free survival

Safety Issue:

No

Principal Investigator

Tatsuo Kanda, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Niigata University Medical and Dental Hospital

Authority:

United States: Federal Government

Study ID:

CDR0000615624

NCT ID:

NCT00769782

Start Date:

October 2008

Completion Date:

Related Keywords:

  • Gastrointestinal Stromal Tumor
  • Metastatic Cancer
  • gastrointestinal stromal tumor
  • liver metastases
  • Neoplasm Metastasis
  • Neoplasms
  • Neoplasms, Second Primary
  • Gastrointestinal Stromal Tumors

Name

Location